. . . . . . . . . . . . . . "a(SCHEM:\"SB-202190\") -| kin(p(HGNC:MAPK14))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "The specific p38 MAP kinase inhibitor, SB202190, significantly decreased the cytotoxicity and increased the survivin levels in NO donor-treated and inducible NOS-transfected cells." . . "Selventa" . . . . "2014-07-03T14:32:17.269+02:00"^^ . . .